Fanconi Anemia, Complementation Group D1

Explore clinical trials studying Fanconi Anemia, Complementation Group D1. Study availability and eligibility vary by location and protocol.

25 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Fanconi Anemia, Complementation Group D1 trial results

Completed

NCT00776958

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
Locations: University of Alabama, Birmingham/Department of OB/GYN Birmingham, Alabama, United States

USC/Norris Comprehensive Cancer Center Los Angeles, California, United States

NYU Cancer Institute New York, United States

UT MD Anderson Cancer Center Houston, Texas, United States

Completed

NCT00677079

Conditions: Advanced Epithelial Ovarian Cancer, Fanconi Anemia, Complementation Group D1, Primary Peritoneal Cancer
Locations: New York, United States

Completed

NCT00165152

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +19 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Active, Not Recruiting

NCT04613440

Conditions: BRCA1 Mutation, BRCA2 Mutation, Fanconi Anemia, Complementation Group D1
Locations: Weill Cornell Medicine New York, United States

Duke University Durham, North Carolina, United States

MD Anderson Cancer Center Houston, Texas, United States

Active, Not Recruiting

NCT03344965

Conditions: ATM Gene Mutation, BRIP1 Gene Mutation, Breast Diseases, +14 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

University of California, San Francisco San Francisco, California, United States

University of Chicago Chicago, Illinois, United States

Indiana University Indianapolis, Indiana, United States

View all 20 locations